For decades, public health officials have fretted about insurance companies having access to  genetic testing and using the results to deny coverage or set higher rates for people likely to get certain diseases. That was true even before people could casually send in a swab to a company like 23andme, AncestryDNA or Family TreeDNA, to be tested.  Those results end …